343 Oyster Point Boulevard
South San Francisco, CA 94080
Full Time Employees: 8
|Dr. Susan M. Molineaux Ph.D.||Founder, CEO, Pres & Director||625.81k||N/A||1954|
|Ms. Stephanie Wong||CFO & Sec.||752.42k||N/A||1974|
|Dr. Christopher J. Molineaux Ph.D.||Sr. VP of Devel.||N/A||N/A||1953|
|Mr. Frank Parlati Ph.D.||Sr. VP of Research||N/A||N/A||1969|
|Dr. Susan B. Demo Ph.D.||Sr. VP of R&D Operations||N/A||N/A||N/A|
|Dr. Allison Dillon Ph.D.||Sr. VP of Commercial & Portfolio Strategy||N/A||N/A||N/A|
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Calithera Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.